Synthesis of new 2-alkylamino-1,4-naphthoquinones as inhibitors of coenzyme Q and as antimalarials.
D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D008928:Mitochondria / Q000201:enzymology; D009285:Naphthoquinones / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D010961:Plasmodium / Q000187:drug effects; D014451:Ubiquinone / Q000037:antagonists & inhibitors*
D000962:Antimalarials; D009285:Naphthoquinones; D014451:Ubiquinone